RANKINGS

POPULAR STOCKS

genedrive plc

LSE:GDR.L

Location

United Kingdom

Market Cap

USD 10.63 M

Share Price

USD 0.02

Avg Daily Volume

7,073,914

Change (1 day)

0.62%

Change (1 year)

-14.50%

Change (YTD)

-36.15%

genedrive plc Shareholders' Equity for the year ending June 30, 2024

genedrive plc Shareholders' Equity is NA for the year ending June 30, 2024. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
Key data
Date Shareholders' Equity Cash and Short-Term Investments Receivables Inventory
Market news
LSE: GDR.L

genedrive plc

CEO Dr. Gino Miele Ph.D.
IPO Date April 4, 2007
Location United Kingdom
Headquarters The CTF Building
Employees 43
Sector 🏥 Health Care
Industries
Biotechnology
🔬 Clinical Trials
🩺 Medical Instruments
💻 Telehealth
Description

genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive, a patented small polymerase chain reaction, which enables rapid nucleic acid amplification and detection from various sample types, including plasma, sputum, and buccal swabs. Its Genedrive platform offers Genedrive HCV ID Kit, a qualitative molecular solution for Hepatitis C Virus testing; Genedrive BioPlex for the rapid determination of military biothreats from pathogens; Genedrive MT-RNR1-ID Kit, a rapid genetic test in an emergency neonatal care setting; and Genedrive Connect app, an android-based mobile app that allows added data management flexibility and results transmission. The company serves biotechnology and pharmaceutical industries in the United Kingdom, Europe, the United States, and internationally. It has a collaboration agreement with Beckman Coulter Life Sciences to automate the laboratory PCR testing process for COVID-19. The company was formerly known as Epistem Holdings Plc and changed its name to genedrive plc in July 2016. genedrive plc was founded in 2000 and is headquartered in Manchester, the United Kingdom.

Similar companies

HEMO.L

Hemogenyx Pharmaceuticals Plc

USD 2.36

1.31%

NCYT.L

Novacyt S.A.

USD 0.60

3.63%

AVCT.L

Avacta Group Plc

USD 0.41

4.00%

StockViz Staff

June 21, 2025

Any question? Send us an email